The PRELIEVE trial:Final 1-year outcomes of the prospective atrial flow regulator study

Back

ESC Professional Premium Access

The PRELIEVE trial:Final 1-year outcomes of the prospective atrial flow regulator study

Session: Complex and novel interventions for heart failure

Topic: Multidisciplinary Interventions

Speaker: Doctor C. Paitazoglou (Luebeck, DE)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Christina Paitazoglou

University Heart Center, Luebeck (Germany)

1 presentation

0 follower

7 more presentations in this session

Transcatheter endomyocardial alginate-hydrogel injection for treatment of heart failure

Speaker: Doctor B. Wang (Galway, IE)

Access

Abstract

Slides

Interventional rhythm control is associated with an improved long-term prognosis of patients with atrial fibrillation undergoing transcatheter edge-to-edge mitral valve repair

Speaker: Doctor C. Waechter (Marburg, DE)

Tricuspid regurgitation and heart failure: the faith of treated vs untreated cohort in the percutaneous era

Speaker: Doctor E. Zancanaro (Milan, IT)

Impact of sacubitril valsartan initiation in patients with HFrEF and severe mitral regurgitation referred for percutaneous mitral repair

Speaker: Mrs M. Rivadeneira Ruiz (Madrid, ES)

A proactive care pathway that improves medical therapy for patients with heart failure with reduced ejection fraction and implantable cardiac devices

Speaker: Doctor H. Williams (Bristol, GB)

Access the full session

Complex and novel interventions for heart failure

Speakers: Doctor C. Paitazoglou, Doctor B. Wang, Doctor C. Waechter, Doctor E. Zancanaro, Mrs M. Rivadeneira Ruiz...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources